Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/24 16:20 | 11/19/24 | ACRS | Health | Drug | Pharmaceutical Preparations | Mehra Anand | PA | D | 1 | P | 1,500 | 2.25 | 0 | 667 | 999% | 710 | D | |||||||||||||||
8/5/24 15:57 | 8/2/24 | ACRS | Health | Drug | Pharmaceutical Preparations | Leonard Braden Michael | IN | T | 7 | P.m | 5,592 | 1.15 | 0 | 4,854 | 21 | 28,294 | I | |||||||||||||||
3/5/24 16:58 | 3/1/24 | ACRS | Health | Drug | Pharmaceutical Preparations | Powell Andrew Kenneth William | PA | D | 1 | P.m | 18 | 1.24 | 0 | 15 | 101 | 29 | D | |||||||||||||||
9/7/23 16:16 | 9/6/23 | ACRS | Health | Drug | Pharmaceutical Preparations | Balthaser Kevin | PA | O | CFO | 1 | P | 75 | 7.90 | 0 | 9 | 159 | 15 | D | ||||||||||||||
8/28/23 16:39 | 8/28/23 | ACRS | Health | Drug | Pharmaceutical Preparations | Loerop James | PA | O | Chief Bu | 1 | P | 100 | 6.80 | 0 | 15 | 211 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |